AMED Amedisys Inc

Price (delayed)

$93.69

Market cap

$3.06B

P/E Ratio

936.9

Dividend/share

N/A

EPS

$0.1

Enterprise value

$3.45B

Amedisys, Inc. is a leading healthcare at home Company delivering personalized home health, hospice and personal care. Amedisys is focused on delivering the care that is best for its patients, ...

Highlights
The company's debt fell by 13% YoY
The gross margin has increased by 2.5% YoY
The net income has shrunk by 98% YoY but it has increased by 14% QoQ
AMED's EPS has plunged by 97% YoY but it is up by 11% from the previous quarter
The P/E is 88% above the last 4 quarters average of 498.5

Key stats

What are the main financial stats of AMED
Market
Shares outstanding
32.63M
Market cap
$3.06B
Enterprise value
$3.45B
Valuations
Price to book (P/B)
2.94
Price to sales (P/S)
1.37
EV/EBIT
42.3
EV/EBITDA
24.41
EV/Sales
1.55
Earnings
Revenue
$2.23B
EBIT
$81.64M
EBITDA
$141.5M
Free cash flow
$112.31M
Per share
EPS
$0.1
Free cash flow per share
$3.44
Book value per share
$31.89
Revenue per share
$68.28
TBVPS
$20.82
Balance sheet
Total assets
$2.03B
Total liabilities
$933.9M
Debt
$490.21M
Equity
$1.04B
Working capital
-$892,000
Liquidity
Debt to equity
0.47
Current ratio
1
Quick ratio
0.88
Net debt/EBITDA
2.8
Margins
EBITDA margin
6.4%
Gross margin
44.3%
Net margin
0.1%
Operating margin
7.4%
Efficiency
Return on assets
0.1%
Return on equity
0.3%
Return on invested capital
12.9%
Return on capital employed
5.2%
Return on sales
3.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMED stock price

How has the Amedisys stock price performed over time
Intraday
0.37%
1 week
0.09%
1 month
-1.14%
1 year
-3.57%
YTD
-1.44%
QTD
-1.44%

Financial performance

How have Amedisys's revenue and profit performed over time
Revenue
$2.23B
Gross profit
$986.4M
Operating income
$165.61M
Net income
$2.65M
Gross margin
44.3%
Net margin
0.1%
The company's net margin has shrunk by 98% YoY
The net income has shrunk by 98% YoY but it has increased by 14% QoQ
The company's operating margin fell by 12% YoY
AMED's operating income is down by 11% year-on-year

Growth

What is Amedisys's growth rate over time

Valuation

What is Amedisys stock price valuation
P/E
936.9
P/B
2.94
P/S
1.37
EV/EBIT
42.3
EV/EBITDA
24.41
EV/Sales
1.55
AMED's EPS has plunged by 97% YoY but it is up by 11% from the previous quarter
The P/E is 88% above the last 4 quarters average of 498.5
The P/B is 55% less than the 5-year quarterly average of 6.5 but 9% more than the last 4 quarters average of 2.7
AMED's equity is up by 3.3% since the previous quarter and by 2.4% year-on-year
The P/S is 45% less than the 5-year quarterly average of 2.5 but 5% more than the last 4 quarters average of 1.3

Efficiency

How efficient is Amedisys business performance
The ROA has dropped by 98% year-on-year
The ROE has plunged by 98% YoY but it has soared by 50% from the previous quarter
AMED's ROS has plunged by 56% YoY but it is up by 9% from the previous quarter
The ROIC has plunged by 51% YoY but it has grown by 15% from the previous quarter

Dividends

What is AMED's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMED.

Financial health

How did Amedisys financials performed over time
AMED's total assets is 117% higher than its total liabilities
The current ratio has increased by 9% QoQ but it has decreased by 6% YoY
The quick ratio has increased by 4.8% QoQ but it has decreased by 3.3% YoY
The company's debt is 53% lower than its equity
The debt to equity has contracted by 15% YoY and by 2.1% from the previous quarter
The company's debt fell by 13% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.